Warfarin
Jantoven
Vitamin K Antagonist (Anticoagulant)
NADAC/unit
$0.0785
No Shortage
Tier 1: 1734.0%
6 Manufacturers
54 ANDAs
Warfarin sodium tablets are indicated for: Prophylaxis and treatment of venous thrombosis and its extension, pulmonary embolism (PE).
vs. brand Jantoven: Generic saves up to 99% per unit
Market Intelligence
2024-01-03 Class II Recall: CARDINAL HEALTHCARE
2024-01-03 Class II Recall: CARDINAL HEALTHCARE
Generic Manufacturers
AMNEAL PHARMACEUTICALSINVAGEN PHARMACEUTICALS INCPLIVA INCTARO PHARMACEUTICAL INDUSTRIES LTDUPSHER SMITH LABORATORIES LLCZYDUS PHARMACEUTICALS USA INC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.